Upregulated expression of S100A6 in human gastric cancer

Journal of Digestive Diseases

Volumn 8, Issue 4, 2007, Pages 186-193

  Yang, Yan Qing ^a,b   Zhang, Lan Jing ^a   Dong, Hui ^c   Jiang, Chang Long ^a   Zhu, Zheng Gang ^a   Wu, Jian Xin ^a   Wu, Yun Lin ^a   Han, Jun Song ^b   Xiao, Hua Sheng ^b   Gao, Heng Jun ^b   Zhang, Qing Hua ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NATIONAL ENGINEERING CENTER FOR BIOCHIP AT SHANGHAI   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Microarray; Neoplasma of the stomach; S100A6; Serial analysis of gene expression; Tissue microarray

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; DOXORUBICIN; FLUOROURACIL; MESSENGER RNA; PROTEIN S 100; S100A6 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; COMPARATIVE STUDY; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUCOSA; STOMACH TUMOR; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOXORUBICIN; FLUOROURACIL; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; S100 PROTEINS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 85047688874     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2007.00311.x     Document Type: Article

References (34)

1. Ridinger K, Ilg EC, Niggli FK, Heizmann CW, Schafer BW. Clustered organization of S100 genes in human and mouse. Biochim Biophys Acta 1998; 448: 254-63.
2. Calabretta B, Kaczmarek L, Mars W et al. Cell-cycle-specific genes differentially expressed in human leukemias. Proc Natl Acad Sci USA 1985; 82: 4463-7.
3. Kuznicki J, Filipek A. Purification and properties of a novel Ca2+-binding protein (10.5 kDa) from Ehrlich-ascites-tumour cells. Biochem 1987; 247: 663-7.
4. Otterbein LR, Kordowska J, Witte-Hoffmann C, Wang CL, Dominguez R. Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 2002; 10: 557-67.
5. Calabretta B, Battini R, Kaczmarek L, de Riel JK, Baserga R. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 1986; 261: 12628-32.
6. Courtois-Coutry N, Le Moellic C, Boulkroun S et al. Calcyclin is an early vasopressin-induced gene in the renal collecting duct. Role in the long term regulation of ion transport. J Biol Chem 2002; 277: 25728-34.
7. Okazaki K, Niki I, Iino S, Kobayashi S, Hidaka H. A role of calcyclin, a Ca(2+)-binding protein, on the Ca(2+)-dependent insulin release from the pancreatic beta cell. J Biol Chem 1994; 269: 6149-52.
8. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003; 8: 848-54.
9. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 2002; 277: 28848-52.
10. Nowotny M, Spiechowicz M, Jastrzebska B, Filipek A, Kitagawa K, Kuznicki J. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins. J Biol Chem 2003; 278: 26923-8.
11. Kuznicki J, Kordowska J, Puzianowska M, Wozniewicz BM. Calcyclin as a marker of human epithelial cells and fibroblasts. Exp Cell Res 1992; 200: 425-30.
12. Filipek A, Puzianowska M, Cieslak B, Kuznicki J. Calcyclin-Ca(2+)-binding protein homologous to glial S-100 beta is present in neurones. Neuroreport 1993; 4: 383-6.
13. Yamashita N, Ilg EC, Schafer BW, Heizmann CW, Kosaka T. Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J Comp Neurol 1999; 404: 235-57.
14. Luu HH, Zhou L, Haydon RC et al. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 2005; 229: 135-48.
15. Vimalachandran D, Greenhalf W, Thompson C et al. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 2005; 65: 3218-25.
16. Shekouh AR, Thompson CC, Prime W et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003; 3: 1988-2001.
17. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997; 74: 464-9.
18. Kim J, Kim J, Yoon S et al. S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol Res 2002; 23: 274-6.
19. Komatsu K, Andoh A, Ishiguro S et al. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 2000; 6: 172-7.
20. Komatsu K, Murata K, Kameyama M et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology 2002; 63: 192-200.
21. Rehman I, Cross SS, Catto JW et al. Promoter hypermethylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Prostate 2005; 65: 322-30.
22. Rehman I, Cross SS, Azzouzi AR et al. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 2004; 91: 739-44.
23. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol/Hematol 2005; 54: 209-41.
24. Huang J, Miao X, Jin W et al. Serial analysis of gene expression in the silkworm. Bombyx Mori Genomics 2005; 86: 233-41.
25. Wang L, Zhu JS, Song MQ, Chen GQ, Chen JL. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 2006; 12: 6949-54.
26. Li RY, Zhang QH, Liu Z et al. Effect of short-term and long-term fasting on transcriptional regulation of metabolic genes in rat tissues. Biochem Biophys Res Commun 2006; 344: 562-70.
27. Zheng PZ, Wang KK, Zhang QY et al. Systems Analysis of Transcriptome and Proteome in Retinoic Acid/Arsenic Trioxide Combination-Induced Cell Differentiation/ Apoptosis of Acute Promyelocytic Leukemia. Proc Natl Acad Sci USA 2005; 102: 7653-8.
28. Xu C, Zheng P, Shen S et al. NMR Structure and Regulated Expression in APL Cell of Human SH3BGRL3. FEBS Lett 2005; 579: 2788-94.
29. Ohuchida K, Mizumoto K, Ishikawa N et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005; 11: 7785-93.
30. Shi Y, Hu W, Yin F et al. Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP). Gastric Cancer 2004; 7: 160-6.
31. Nowotny M, Bhattacharya S, Filipek A, Krezel AM, Chazin W, Kuznicki J. Characterization of the interaction of calcyclin (S100A6) and calcyclin-binding protein. J Biol Chem 2000; 275: 31178-82.
32. MAQC Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24: 1151-61.
33. Du Y, Wang K, Fang H et al. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood 2006; 107: 1582-90.
34. Chang HM, Jung KH, Kim TY et al. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol 2002; 13: 1779-85.